ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "quality improvement"

  • Abstract Number: 1190 • 2019 ACR/ARP Annual Meeting

    A Quality Improvement Project to Increase Documentation Efficiency in an Academic Rheumatology Practice

    David Leverenz1, Jon Golenbiewski 1, Brian Andonian 1, Katherine Kaufman 1, Philip Chu 1, Mithunan Maheswaranathan 1, Andrew Johannemann 1, Jayanth Doss 2 and Lisa Criscione-Schreiber 2, 1Duke University, Durham, NC, 2Duke University, Durham

    Background/Purpose: All providers, including rheumatologists, spend approximately half of their day documenting in an electronic health record (EHR). Excessive documentation is a key contributor to…
  • Abstract Number: 1192 • 2019 ACR/ARP Annual Meeting

    Effect of a Clinical Decision Support System on a Quality Indicator of Glucocorticoid-induced Osteoporosis and Trends of Drug Treatment in a Japanese Hospital

    Hiroki Ozawa1, Sho Fukui 1, Genki Kidoguchi 1, Takehiro Nakai 2, Satoshi Kawaai 1, Ayako Koido 1, Yukihiko Ikeda 1, Masei Suda 1, Haruyuki Yanaoka 1, Hisanori Shimizu 1, Hiromichi Tamaki 1, Tokutaro Tsuda 1, Mitsumasa Kishimoto 3, Kenichi Yamaguchi 1 and Masato Okada 1, 1St.Luke International Hospital Immuno-Rheumatology Center, Tokyo, Japan, 2St.Luke International Hospital Immuno-Rheumatology Center, Tokyo, Tokyo, Japan, 3Immuno-Rheumatology Center, St. Luke’s International Hospital, Tokyo, Japan

    Background/Purpose: Glucocorticoid-induced osteoporosis (GIOP) is a common, preventable and treatable complication of glucocorticoid therapy. We defined quality indicator (QI) for GIOP and took a hospital-wide…
  • Abstract Number: 424 • 2018 ACR/ARHP Annual Meeting

    Occult Extractable Synovial Fluid in Inflammatory and Non-Inflammatory Arthritis of the Knee

    Noelle Rolle1, Irum Jan2, Wilmer Sibbitt Jr.1, Philip Band3, William Hayward4, Maheswari Muruganandam1, N. Suzanne Emil1, Monthida Fangtham1, Roderick Fields1 and Arthur Bankhurst1, 1Rheumatology, University of New Mexico Health Sciences Center, Albuquerque, NM, 2Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, 3NYU School of Medicine, New York, NY, 4The Department of Exercise and Sport Sciences, New Mexico Highlands University, Las Vegas, NM

    Background/Purpose: We hypothesized that mechanical compression of the knee in rheumatoid arthritis (RA) and osteoarthritis (OA) would mobilize occult extractable fluid and improve arthrocentesis success.Methods:…
  • Abstract Number: 2857 • 2018 ACR/ARHP Annual Meeting

    An Electronic Audit, Reporting, and Data Correction System Improves the Quantity and Quality of Observational Data Collected for US Veterans Enrolled in the Veterans Affairs Rheumatoid Arthritis Registry

    Grant W. Cannon1,2, Jorge Rogas2, Neill Bell3, Joshua Baker4, Gail S. Kerr5, Angelo Gaffo6, J. Steuart Richards7, Jennifer Barton8, Pascale Schwab8, Ted R. Mikuls9, Namrata Singh10, Liron Caplan11, Deana Lazaro12, Andreas Reimold13 and Brian Sauer2, 1Division of Rheumatology, Salt Lake City VA Medical Center and University of Utah, Salt Lake City, UT, 2Salt Lake City VA Medical Center and University of Utah, Salt Lake City, UT, 3Salt Lake City VA Medical Center and University of Utah, Dallas VA Medical Center, Dallas, TX, 4Philadelphia VA Medical Center and University of Pennsylvania, Philadelphia, PA, 5Washington VA Medical Center, Georgetown and Howard Universities, Washington, DC, 6Birmingham VA and University of Alabama at Birmingham, Birmingham, AL, 7Pittsburgh VA Medical Center and University of Pittsburgh, Pittsburgh, PA, 8VA Portland Health Care System and Oregon Health and Science, Portland, OR, 9VA Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, NE, 10Internal Medicine, Iowa City VA Medical Center and University of Iowa, Iowa City, IA, 11Div of Rheumatology, Denver VA Medical Center and University of Colorado, Aurora, CO, 12Brooklyn VA Medical Center and SUNY Downstate, Brooklyn, NY, 13Rheumatology, Dallas VA Medical Center and University of Texas - Southwestern, Dallas, TX

    Background/Purpose:   The Veterans Affairs (VA) Rheumatoid Arthritis (RA) (VARA) registry is an observational cohort study of US Veterans with RA at 11 VA Medical…
  • Abstract Number: 326 • 2018 ACR/ARHP Annual Meeting

    Implementation of a Treat-to-Target Quality Improvement Program for Rheumatoid Arthritis Management Using Real-Time Patient Reported Outcome Measures

    Malka Forman1, Cianna Leatherwood2, Chang Xu1, Eunji Ko1, Bing Lu3, Maura D. Iversen4, Daniel Solomon2 and Sonali Desai2, 1Brigham and Women's Hospital, Boston, MA, 2Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, 3Division of Rheumatology, Immunology and Allergy, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, 4Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA

    Background/Purpose: Changing clinical practice patterns and incorporation patient-reported outcome measures (PROMs) for disease activity assessment into routine workflow is challenging. We sought to integrate a…
  • Abstract Number: 338 • 2018 ACR/ARHP Annual Meeting

    Implementation of an Automated Phrase to Increase Awareness of Cardiovascular Risk in Rheumatoid Arthritis Patients in an Urban Fellows Rheumatology Clinic

    Leslie Anne Cassidy1, Jennifer Brandt1, Alison Gizinski2, Arezou Khosroshahi1, Gaobin Bao1 and S. Sam Lim3, 1Department of Medicine, Division of Rheumatology, Emory University School of Medicine, Atlanta, GA, 2Department of Medicine, Division of Rheumatology, Emory University School of Medicine, Atlanta, Georgia, 3Emory University School of Medicine, Atlanta, GA

    Background/Purpose: Rheumatoid arthritis (RA) is a significant and well-established risk factor for atherosclerotic cardiovascular disease (ASCVD). Cardiovascular risk stratification is often left to the primary…
  • Abstract Number: 102 • 2017 ACR/ARHP Annual Meeting

    Incorporating Temporal Artery Ultrasound in a UK District General Hospital with No Prior Colour Doppler Sonography Service: An Encouraging Preliminary Analysis

    Othman Kirresh1, Chintu Gademsetty2 and Charles Li1, 1Rheumatology, NHS Royal Surrey County Hospital, Surrey, United Kingdom, 2Radiology, NHS Royal Surrey County Hospital, Surrey, United Kingdom

    Background/Purpose: Temporal Arteritis (TA) is the most common large vessel vasculitis, affecting adults over the age of 50. It is associated with significant morbidity due…
  • Abstract Number: 385 • 2017 ACR/ARHP Annual Meeting

    Reliable Implementation of a Hepatitis B Serology Screening and Vaccination Process for Immunocompromised Pediatric Rheumatology Patients

    Emily A. Smitherman1, Adam Furnier2, Allen Watts1, Sandra Kramer1, Elizabeth Joy Baker1, Dana MH Dykes3, Rebecca Brady4 and Jennifer L. Huggins5, 1Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2James M. Anderson Center for Health Systems Excellence, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 3Gastroenterology, Hepatology, and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 4Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 5Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

    Background/Purpose: Vaccine-preventable infections, including reactivation of hepatitis B virus, are a leading cause of morbidity and mortality in immunocompromised patients. Guidelines recommend that all immunosuppressed…
  • Abstract Number: 1080 • 2017 ACR/ARHP Annual Meeting

    Electronic Patient Reported Outcomes Increase Pediatric Rheumatology Clinic Operations Efficiency While Increasing Patient and Caregiver Satisfaction

    Y. Ingrid Goh1, Talia Goldberg2, Nicholas Lao3 and Brian M. Feldman4, 1Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON, Canada, 2University of Toronto, Toronto, ON, Canada, 3University of Western Ontario, London, ON, Canada, 4Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada

    Electronic Patient Reported Outcomes Increase Pediatric Rheumatology Clinic Operations Efficiency While Increasing Patient and Caregiver SatisfactionBackground/Purpose: Patient reported outcomes (PROs) are powerful tools that facilitate…
  • Abstract Number: 1087 • 2017 ACR/ARHP Annual Meeting

    Rheumatology Clinic Smoking Cessation Protocol Markedly Increases Quit Line Referrals

    Christie M. Bartels1, Edmond Ramly2, Daniel Panyard3, Diane Lauver4, Heather Johnson5, Zhanhai Li6, Emmanuel Sampene7, Megan Piper8 and Patrick McBride5, 1Rheumatology/Medicine, University of Wisconsin - Madison, Madison, WI, 2Industrial and Systems Engineering, University of Wisconsin College of Engineering, Madison, WI, 3Population Health, University of Wisconsin School of Medicine and Public Health, Madison, WI, 4University of Wisconsin-Madison School of Nursing, Madison, WI, 5Cardiology/Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, 6Biostatistics and Medical Informatics, University of Wisconsin School of Medicine and Public Health, Madison, WI, 7Biostatistics, University of Wisconsin School of Medicine and Public Health, Madison, WI, 8University of Wisconsin Center for Tobacco Research and Intervention, Madison, WI

    Background/Purpose: Smoking predicts higher incidence, greater severity, and reduced treatment responses in rheumatoid arthritis, lupus, and spondyloarthritis. However, cessation advice and quit line referral occur…
  • Abstract Number: 1092 • 2017 ACR/ARHP Annual Meeting

    The Ottawa Biologics Safety and Screening Tool

    Chrisanna Dobrowolski1, Ines Midzic2, Denise Boone2, Anne McCarthy3, Doug Smith2, John Thomson2, Sheryl Izzi4 and Susan Humphrey-Murto2, 1Internal Medicine, The Ottawa Hospital - University of Ottawa, Ottawa, ON, Canada, 2Division of Rheumatology, Department of Medicine, The Ottawa Hospital - University of Ottawa, Ottawa, ON, Canada, 3Division of Infectious Diseases, Department of Medicine, The Ottawa Hospital - University of Ottawa, Ottawa, ON, Canada, 4Division of Endocrinology, Department of Medicine, The Ottawa Hospital - University of Ottawa, Ottawa, ON, Canada

    Background/Purpose : A large proportion of patients with rheumatologic diseases are now being treated with biologic therapies. Estimates of the use of biologics in patients…
  • Abstract Number: 1229 • 2017 ACR/ARHP Annual Meeting

    Factors Affecting FRAX Score Calculation & Treatment in Practice

    Avneet Vig1, Beverly Johnson2, Tony Francis3 and Barbara Mendez-Agrusa4, 1Montefiore Medical Center, Bronx, NY, 2Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, NY, 3Radiology, Albert Einstein College of Medicine, Bronx, NY, 4Medicine, Department of Rheumatology, Albert Einstein College of Medicine, Bronx, NY

    Background/Purpose: Osteoporosis-related fractures causes increased disability and morbidity and mortality. The FRAX algorithm quantifies the 10 year probability of a hip or major osteoporotic fracture.…
  • Abstract Number: 1796 • 2017 ACR/ARHP Annual Meeting

    Benefits and Sustainability of a Learning Collaborative for Implementation of Treat to Target in Rheumatoid Arthritis:  Results of Phase II of a Cluster Randomized Controlled Trial

    Daniel H. Solomon1, Liana Fraenkel2, Zhi Yu3, Bing Lu4, Asaf Bitton5, Agnes Zak6, Cassandra Corrigan7, Jen Agosti8, Leslie R Harrold9, Josef S. Smolen10, Jeffrey N. Katz11 and Elena Losina12, 1Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 2Rheumatology, Rheumatology, Yale University School of Medicine, New Haven, CT, New Haven, CT, 3Rheumatology Immunology & Allergy, Brigham and Women's Hospital, Boston, MA, 4Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 5Medicine, Brigham and Women's Hospital, Boston, MA, 6Brigham and Women's Hospital, Boston, MA, 7Rheumatology, Brigham and Women's Hospital, Boston, MA, 8JRA Consulting, Andover, MA, 9University of Massachusetts Medical School, Worcester, MA, 10Medical University Vienna, Division of Rheumatology, Department of Internal Medicine III, Vienna, Austria, 11Rheumatology, Immunology, and Allergy, Brigham & Women's Hospital, Boston, MA, 12Orthopaedic and Arthritis Center for Outcomes Research, Department of Orthopedic Surgery, Brigham & Women's Hospital, Boston, MA

    Background/Purpose:   Treat to target (TTT) is a recommended strategy in the management of rheumatoid arthritis (RA), but its uptake in routine rheumatologic care in…
  • Abstract Number: 1797 • 2017 ACR/ARHP Annual Meeting

    Insights from Treating to Target in Rheumatoid Arthritis at an Academic Medical Center

    Malithi Jayasundara1, Ryan Jessee2, Jason Weiner3, Tayseer Haroun4, Stephanie Giattino5, Atul Kapila4, Jenelle Hall4, Lisa Carnago4 and Lisa Criscione-Schreiber6, 1Rheumatology, Duke University, Durham, NC, 2Department of Medicine, Division of Rheumatology and Immunology, Duke University, Durham, NC, 3Department of Medicine, Division of Rheumatology and Immunology, Duke University Medical Center, Durham, NC, 4Duke University, Durham, NC, 5Rheumatology, Duke University Medical Center, Durham, NC, 6Internal Medicine, Duke University Medical Center, Durham, NC

    Background/Purpose: Current RA guidelines recommend treating to a target of remission or low disease activity (RM/LDA) state.  In a prior quality improvement (QI) project, our…
  • Abstract Number: 1798 • 2017 ACR/ARHP Annual Meeting

    Effective Implementation and Evaluation of Quality Improvement Initiatives in a Safety Net Hospital Rheumatology Clinic

    Alfredo Aguirre1, Laura Trupin2, Mary Margaretten3, Sarah Goglin4 and Jinoos Yazdany2, 1Internal Medicine, University of California, San Francisco, SAN FRANCISCO, CA, 2Medicine/Rheumatology, University of California San Francisco, San Francisco, CA, 3Medicine, University of California San Francisco, San Francisco, CA, 4Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA

    Background/Purpose: Vulnerable populations with autoimmune rheumatic diseases are at higher risk for disparities in care. To address these health inequalities we developed and evaluated 2…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology